10x Genomics is trading 4.1% down at $46.08 as investors lock in profits following a period of significant upward momentum.
- The stock recently experienced a sharp 9%+ jump on July 21 and an 11% surge earlier in the month linked to a partnership with Anthropic AI.
- Today's pullback suggests a cooling of prior AI-related enthusiasm rather than any new negative, company-specific developments.